Leveraging Implementation Science for Medicinal Products

This white paper discusses the application of implementation science to enhance the value proposition for medicinal products and devices. It outlines the challenges faced in translating clinical research into practice, particularly in the context of new medicinal products. The paper details how implementation science can address gaps in uptake, integration, and sustained adoption of innovations in clinical care. It presents various strategies and frameworks that can improve operational efficiencies in clinical trials, increase medication adoption, and tackle issues such as nonadherence. The authors provide a case study on the Pfizer-BioNTech COVID-19 vaccine, illustrating how implementation science could have mitigated barriers to uptake. Additionally, the paper emphasizes the importance of identifying barriers and implementing strategies throughout the drug development lifecycle to enhance patient experiences and outcomes. Overall, it serves as a guide for sponsors to leverage implementation science in improving the effectiveness and efficiency of medicinal product management.